OPPM
ALBO

Opus Point Partners Management’s Albireo Pharma Inc ALBO Stock Holding History

Opus Point Partners Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-21,667
Closed -$670K – 60
2015
Q2 		$670K Buy
+21,667
New +$728K 0.53% 44

Other funds holding ALBO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Opus Point Partners Management's ALBO Position: Q3 2015 in Review

Opus Point Partners Management sold out of Albireo Pharma Inc (ALBO) in Q3 2015, closing a stake of 21,667 shares — an estimated $670K sold.

Opus Point Partners Management first reported a position in ALBO in Q2 2015 and held it in 1 quarter. The position peaked at $670K in Q2 2015. 38 funds tracked by Wall St. Rank hold ALBO as of Q3 2015.

  • Opus Point Partners Management reported no remaining Albireo Pharma Inc position as of Q3 2015 after selling out during the quarter.
  • Opus Point Partners Management sold 21,667 Albireo Pharma Inc shares in Q3 2015, an estimated $670K.
  • Opus Point Partners Management first reported a position in Albireo Pharma Inc in Q2 2015 and held it in 1 quarter.
  • Opus Point Partners Management's Albireo Pharma Inc position peaked at $670K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2015.

Based on Opus Point Partners Management's 13F filing for Q3 2015, filed 16 Nov 2015.